Free Trial

Vertex, Incyte fall; Precigen, Magnachip rise

NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Friday:

Vertex Pharmaceuticals Inc., down $23.75 to $193.02.

The biotechnology company ended development of a potential treatment for a genetic condition that targets the liver.

Dave & Buster's Entertainment Inc., down $1.21 to $42.87.

Investors remained cautious about the beaten down restaurant and arcade owner, despite reporting surprisingly good first-quarter earnings.

Incyte Corp., down $4.95 to $82.58.

The biotechnology company's potential eczema cream ruxolitinib faces a delayed regulatory review.

Precigen Inc., up 34 cents to $7.33.

The biotechnology company gave investors an encouraging development update for a potential diabetes treatment.

Magnachip Semiconductor Corp., up $2.86 to $25.91.

The chipmaker, which agreed to a buyout from South Dearborn, received a bigger offer from Cornucopia Investment Partners.

Royal Caribbean Group, down 54 cents to $90.09.

The cruise line operator said two guests sharing a stateroom onboard its Celebrity Millennium tested positive for COVID-19.

MKS Instruments Inc., down $3.78 to $177.56.

The maker of analysis and processing equipment for semiconductor companies is reportedly seeking to buy Atotech.

Western Digital Corp., up $1.22 to $74.78.

The maker of hard drives for businesses and personal computers gave investors an encouraging update during a business conference.

Should You Invest $1,000 in Magnachip Semiconductor Right Now?

Before you consider Magnachip Semiconductor, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Magnachip Semiconductor wasn't on the list.

While Magnachip Semiconductor currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.

Companies Mentioned in This Article

CompanyMarketRankâ„¢Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
MKS (MKSI)
4.2782 of 5 stars
$104.770.1%0.84%31.27Moderate Buy$130.82
Vertex Pharmaceuticals (VRTX)
4.7263 of 5 stars
$454.64-0.5%N/A-115.98Moderate Buy$511.62
Incyte (INCY)
4.4344 of 5 stars
$68.460.4%N/A213.94Hold$74.53
Magnachip Semiconductor (MX)
2.8482 of 5 stars
$4.112.0%N/A-3.21Moderate Buy$6.00
Compare These Stocks  Add These Stocks to My Watchlist 

Featured Articles and Offers

Recent Videos

3 Cheap Growth Stocks Set to Explode This Summer
The Next NVIDIA? Quantum Computing Stocks Set for Explosive Growth
5 Stocks to BUY NOW in July 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines